Kynda (formerly Keen 4 Greens) is a German technology supplier for mycelium biomass fermentation. The company started off as a plant-based meat developer offering vegan burgers and nuggets, but has since transitioned into a B2B model and now provides plug-and-play bioreactors.
Kynda bioreactors offer low-cost decentralized solutions for customers to ferment mycelium in-house. According to the company, this method provides advantages in terms of flexibility, versatility, and scalability over large-scale centralized systems. In addition, these bioreactors claim to work with multiple feedstock options and are weather- and climate-resistant.
In March 2024, the company debuted Kynda Meat, a sustainable, mycelium-based food ingredient which is exempt from the EU novel foods regulatory process. It claims to offer a 37% protein content in dry matter and contains all nine essential amino acids, vitamins, and fiber while being low in fat. In May 2024, Kynda began construction of a large-scale facility to produce Kynda Meat. This 6,200 sq m facility will have two 720 sq m production halls and utilize Kynda’s plug-and-play bioreactors to produce 2,500 tons of Kynda Meat.
Key customers and partnerships
In December 2022, Kynda delivered a mobile fermentation unit to the German Institute of Food Technologies (DIL), a non-profit research provider, for on-site mycelium production and to explore potential FoodTech use cases.
In March 2024, the company partnered with Germna plant-based meat company The Raging Pig Co to develop its mycelium-based food ingredient Kynda Meat.
Funding and financials
In February 2022, the startup secured EUR 1.8 million (~USD 2 million) in seed funding led by FoodLabs, with participation from Sustainable Food Ventures and Shio Capital. The funds were earmarked for the expansion of its manufacturing facilities. In November 2023, the company secured a non-dilutive grant from Germany's Ministry of Food and Agriculture. The grant was earmarked for a collaborative project with DIL, focusing on increasing the efficiency and scalability of mycelial protein production. In addition, the company also launched a seed funding round to raise USD 4 million.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.